Tag - CDNA

Markets

BTIG cuts CareDx to hold on CMS policy changes; removal of guidance

BTIG downgraded CareDx (NASDAQ:CDNA) to “neutral” from “buy” and removed its price target. The stock closed at $8.59 on May 10. CareDx is a market leader in blood-based testing for both heart and kidney transplant...

May 11, 2023

Developments

Miromatrix, CareDx in pact for bioengineered organs in human transplant

Miromatrix Medical (NASDAQ:MIRO) and CareDx (NASDAQ:CDNA) entered an exclusive partnership aimed at advancing the next wave of innovation using fully transplantable human bioengineered organs. CareDx will develop an...

April 5, 2023

Markets

HCW cuts CareDx to neutral but ups PT to $15

H.C. Wainwright downgraded CareDx (NASDAQ:CDNA) to “neutral” from “buy” but raised its price target to $15 from $14, citing the company’s valuation. The stock closed at $15.78 on June 18. Earlier this month, CareDx held...

June 19, 2018

Tag - CDNA

BTIG cuts CareDx to hold on CMS policy changes; removal of guidance

Miromatrix, CareDx in pact for bioengineered organs in human transplant

HCW cuts CareDx to neutral but ups PT to $15

General

More